Skip to content

Clinical Evaluation of Effect of Agnichikitsa, Virechana (medicated purgation) and Ekangaveera Rasa in Pakshaghata (Paralysis)

Randomised Active Controlled Comparative Clinical Evaluation of Agnichikitsa, Virechana and Ekangaveera Rasa in Pakshaghata (Cerebro-vascular Accident) - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064264
Enrollment
120
Registered
2024-03-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G819- Hemiplegia, unspecified

Interventions

None listed

Sponsors

Dean Faculty of Ayurved Parul University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Haemodynamically stable patients of Pakshaghata (Cerebro-vascular accident) after settle down of the initial emergency condition

Exclusion criteria

Exclusion criteria: 1)Uncontrolled Malignant Hypertension 2)Uncontrolled Diabetes Mellitus 3)Dyslipidemia 4)Intracranial tumours 5)Cerebral Malignancy 6)Cerebral atrophy 7)Motor neuron disease 8)Guillian barre syndrome 9)Cerebral injuries 10)Recurrent and more than one year 11)Associated with major organic and infective pathologies 12)Pregnancy and lactating mother 13)Immune compromised patients HIV AIDS

Design outcomes

Primary

MeasureTime frame
Compare the effect of Agnichikitsa, Virechana and Ekangaveera rasa with conventional management of Pakshaghata (Cerebro-vascular accident) assessing the values using FUGL-MEYER Assessment BERG Balance Scale and BARTHEL Index Timepoint: At baseline and on 15th 30th 45th 60th 75th and on 90th day

Secondary

MeasureTime frame
Compare the effect of Agnichikitsa, Virechana and Ekangaveera rasa with conventional management of Pakshaghata (Cerebro-vascular accident) on the basis of FUGL-MEYER Assessment, BERG Balance Scale and BARTHEL Index. Evaluate the safety of the treatment.Timepoint: At baseline and on 15th 30th 45th 60th 75th and on 90th day

Countries

India

Contacts

Public ContactDr Hariprasad K

Parul Institute of Ayurved

dr.shaileshd@gmail.com9763104451

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026